Condition
Mesothelioma
Estimated Enrollment: 600
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: CA209-743|2016-001859-43
Study First Received: August 31, 2016
Last Updated: April 17, 2017
Estimated Primary Completion Date: October 2020
Primary Outcome Measures:
Overall Survival (OS)|Progression Free Survival (PFS)|Objective Response Rate (ORR)|Disease Control Rate (DCR)|Composite correlation of PD-L1 expression level and efficacy
Sponsors and Collaborators:
Bristol-Myers Squibb|Ono Pharmaceutical Co. Ltd
Website Link: https://ClinicalTrials.gov/show/NCT02899299
